CVEO vs. BSX
CVEO (Civeo Corporation) and BSX (Boston Scientific Corporation) are both stocks. CVEO operates in Specialty Business Services (Industrials), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, CVEO returned 5.20%/yr vs 7.38%/yr for BSX. At a 0.16 correlation, their price movements are largely independent.
Performance
CVEO vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVEO achieves a 45.78% return, which is significantly higher than BSX's -52.18% return. Over the past 10 years, CVEO has underperformed BSX with an annualized return of 5.20%, while BSX has yielded a comparatively higher 7.38% annualized return.
CVEO
- 1D
- 1.28%
- 1M
- -0.77%
- YTD
- 45.78%
- 6M
- 41.63%
- 1Y
- 53.01%
- 3Y*
- 23.68%
- 5Y*
- 15.70%
- 10Y*
- 5.20%
BSX
- 1D
- 2.86%
- 1M
- -21.08%
- YTD
- -52.18%
- 6M
- -52.54%
- 1Y
- -55.45%
- 3Y*
- -5.46%
- 5Y*
- 0.85%
- 10Y*
- 7.38%
CVEO vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CVEO Civeo Corporation | 45.78% | 1.59% | 3.58% | -24.85% | 62.23% | 37.91% | -10.21% | -9.79% | -47.62% | 24.09% |
BSX Boston Scientific Corporation | -52.18% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between CVEO and BSX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since May 19, 2014 | 0.16 |
Fundamentals
CVEO:
-$1.48
BSX:
$2.38
CVEO:
0.47
BSX:
3.31
CVEO:
$667.47M
BSX:
$20.62B
CVEO:
$49.04M
BSX:
$14.52B
CVEO:
$73.11M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVEO vs. BSX — Risk / Return Rank
CVEO
BSX
CVEO vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Civeo Corporation (CVEO) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVEO | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.27 | ||
| Sortino ratioReturn per unit of downside risk | +4.84 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 0.65 | +0.66 |
| Calmar ratioReturn relative to maximum drawdown | 2.61 | -0.94 | +3.55 |
| Martin ratioReturn relative to average drawdown | 7.36 | -2.00 | +9.37 |
Loading charts...
Drawdowns
CVEO vs. BSX - Drawdown Comparison
The maximum CVEO drawdown since its inception was -98.72%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for CVEO and BSX.
Loading charts...
Drawdown Indicators
| CVEO | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.72% | -89.15% | -9.57% |
Max Drawdown (1Y)Largest decline over 1 year | -20.41% | -59.01% | +38.60% |
Max Drawdown (3Y)Largest decline over 3 years | -33.24% | -59.01% | +25.77% |
Max Drawdown (5Y)Largest decline over 5 years | -50.41% | -59.01% | +8.60% |
Max Drawdown (10Y)Largest decline over 10 years | -92.28% | -59.01% | -33.27% |
Current DrawdownCurrent decline from peak | -89.15% | -57.83% | -31.32% |
Average DrawdownAverage peak-to-trough decline | -89.28% | -38.77% | -50.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.22% | 27.71% | -20.49% |
Volatility
CVEO vs. BSX - Volatility Comparison
The current volatility for Civeo Corporation (CVEO) is 9.24%, while Boston Scientific Corporation (BSX) has a volatility of 14.89%. This indicates that CVEO experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVEO | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.24% | 14.89% | -5.65% |
Volatility (6M)Calculated over the trailing 6-month period | 20.90% | 33.07% | -12.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.73% | 35.10% | -3.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.87% | 25.81% | +14.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.71% | 27.34% | +33.37% |
Dividends
CVEO vs. BSX - Dividend Comparison
Neither CVEO nor BSX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% |
CVEO Civeo Corporation | 0.00% | 1.09% | 4.40% | 2.19% |
Financials
CVEO vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Civeo Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CVEO vs. BSX - Profitability Comparison
CVEO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Civeo Corporation reported a gross profit of 0.00 and revenue of 172.67M. Therefore, the gross margin over that period was 0.0%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
CVEO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Civeo Corporation reported an operating income of 0.00 and revenue of 172.67M, resulting in an operating margin of 0.0%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
CVEO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Civeo Corporation reported a net income of -3.81M and revenue of 172.67M, resulting in a net margin of -2.2%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
CVEO and BSX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (14.89%) compared to CVEO (9.24%). In terms of maximum drawdown, CVEO dropped -98.72% vs BSX's -89.15%.
CVEO currently has the higher Sharpe Ratio (1.68 vs -1.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVEO and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer